Exit Notice

You are about to leave ClinicalTrials.gov and go to: To obtain contact information for a study center near you, click here. URL: https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B9991004&StudyName=A%20Phase%201b%2F2%20Open-label%20Study%20To%20Evaluate%20Safety%2C%20Clinical%20Activity%2C%20Pharmacokinetics%20And%20Pharmacodynamics%20Of%20Avelumab%2A%20%28msb0010718c%29%20In%20Combination%20With%20Other%20Cancer%20Immunotherapies%20In%20Patients%20With%20Advanced%20Malignancies

Click on the link to continue or return to ClinicalTrials.gov Home